SpaceXs Potential RecordBreaking IPO Market Expectations and Strategic Hurdles Trump Delays AI Executive Order Signing Citing Concerns Over Potential Blocker to Progress PayWhatYouWant Dining One Restaurants Unconventional Response to Consumer Spending Shifts OpenAIs Confidential IPO Filing Signals Intensifying Race to Public Markets Geopolitical Risks Rise as Gaza Flotilla Activists Allege Mistreatment by Israeli Forces Fed Rate Hike Expectations Surge Futures Market Prices in Increase as Early as December PURR Q1 2026 Earnings Strong EPS Beat Overshadowed by Revenue Uncertainty Spectral AI Inc MDAI Q1 2026 Earnings Missed Estimates as EPS Falls Short Shares Decline Lazard Inc LAZ Q1 2026 Earnings EPS Misses Estimates as Earnings Decline 18 HWBK Q1 2026 Earnings Solid EPS Performance Lifts Shares Universal Display OLED Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Still Gains Pure Cycle Corporation PCYO Q1 2026 Earnings Earnings Per Share of 005 Amidst No Consensus Estimate GormanRupp GRC Gains 227 as Strong Volume Lifts Stock Toward Key Resistance Brandywine Realty Trust BDN Holds Near 300 as Bulls Test Resistance Zone Assembly Biosciences Surges 69 as Buyers Defend Key Support Level ASMB AES Corporation AES Holds Near Key Support After Minimal Decline UMC Slides 071 as Semiconductor Sector Faces Headwinds Key Support at 1731 in Focus Nifty Hovers as Bond Yields FII Flows and Geopolitical Risks Set the Tone for DStreet This Week GFL Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh DexCom DXCM Rallies 326 Testing Resistance After Support Hold Unity Software U Holds Steady Near Support Stock Analysis GEN Restaurant Group Inc GENK Drops 224 as Shares Approach Critical Support Kymera Therapeutics KYMR Slips Over 2 as Biotech Shares Retreat Support Levels in Focus XOMAO Preferred Stock Holds Steady Near Support Attracting Income Investors A SPAC III Acquisition Corp ASPC Holds Steady at 1085 as Investors Await Business Combination Transcontinental Realty Investors TCI Edges Higher in Quiet Session as Support Holds Aclaris Therapeutics ACRS Edges Higher Testing Key Resistance Near 481